SK3 Group, Inc. SKTO Company Overview  Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
SK3 Group, Inc. SKTO Company Overview 

Stock Message Board http://investorshangout.com/search?q=SKTO&...mp;yt1=Go!

SK3 Group, Inc. SKTO Current Price and Quotes
0.0083
Previous Close
0.0087
Open
0.0086

Daily Range
0.0095 - 0.008
52wk Range
0.08 - 0.0002

Volume
5,430,235
Dividend
N/A

Average Vol (3m)
4,153,888
Yield
N/A

SK3 Group, Inc. SKTO

Company Verified Profile
Company Information
80 SW 8th Street
Suite 2000
Miami, FL 33130

Website: http://www.medicalgreens.com
Phone: 305-423-7114
Email: info@medicalgreens.com
Find us on:  

SK3 Group, Inc. SKTO
SK3 Group is acquiring strategic assets in technology, healthcare, and business servicesand has acquired Medical Greens, Inc., a provider of administrative, accounting and other services to California marijuana collectives, authorized under California law. Founded in 2007.

SK3 Group, Inc. SKTO
Financial Reportings and Disclosures
Reporting Status Alternative Reporting Standard
Deregistered a/o Oct 05, 2009
Audited Financials Unaudited
Latest Report Jun 30, 2013 Quarterly Report
CIK 0001106285
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 100 - Agricultural Production-Crops
Business Status Development Stage Company a/o Mar 25, 2013
Incorporated In: DE, USA
Year of Inc. 2007
Employees 3 a/o Mar 25, 2013
Company Officers/Contacts
Artemus Mayor President
Michael Choo Director, Ops.
John Burke Consultant
Company Directors
Kevin Allyn Chairman
Company Notes
Formerly=CTT International Distributors, Inc. until 5-07
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Indeglia & Carney
1900 Main St.
Irvine, CA, 92614
United States

Investor Relations Firm
Not Available

SK3 Group, Inc. SKTO
SKTO Security Details
Share Structure
Market Value1 $4,523,916 a/o Sep 04, 2013
Shares Outstanding 519,990,303 a/o Jun 30, 2013
Float 298,902,135 a/o Mar 25, 2013
Authorized Shares 750,000,000 a/o Jun 30, 2013
Par Value  0.0001
Shareholders
Shareholders of Record 2,900 a/o Mar 25, 2013
Corporate Actions
Ex. Date Record Date Pay Date
Dividend (0.00) May 18, 2007 May 14, 2007 May 17, 2007
Security Notes
Capital Change=shs increased by 3 for 1 split. Ex-date=05/18/2007. Rec date=05/14/2007. Pay date=05/17/2007.
Short Selling Data
Short Interest 214,869 (100%)
Aug 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)
Interwest Transfer Co., Inc.

SK3 Group, Inc. SKTO Recent News


Aug 30, 2013 SKTO Applauds New Justice Department Guidelines on Marijuana Operation Prosecutions
Aug 30, 2013 SKTO Announces New Company Address in California and Conference Call Details
Aug 27, 2013 SK3 Group Distribution of SKTO Products Growing
Aug 26, 2013 SK3 Group Announces New Dedicated Investor Relation Contacts, Comments on AEGY Distribution
Aug 16, 2013 SKTO Announces Acquisition of Accomplished Medical Cannabis Consulting Firm
Jul 29, 2013 SK3 Group Secures CBD Extraction and Purification Technology License
Jul 24, 2013 SK3 Group, Inc. Retains Research and IR Firm Rubicon Capital Advisors
Jun 27, 2013 SKTO Announces Auditor Engagement
Jun 24, 2013 SKTO Announces Merger Terms/Share Distribution
Jun 20, 2013 SKTO Announces Merger Approval, Name/CUSIP Change

12next >

SK3 Group, Inc. SKTO Financials
Period Ending Dec 31, 2012 Dec 31, 2011
Total Revenue - -
Cost of Revenue - -
Gross Profit - -
Operating Expenses
Research and Development - -
Sales, General and Admin. 450 74
Non-Recurring Items - -
Other - -
Operating Income (450) (74)
Income From Continuing Operations
Add'l Income/Expense Items - -
Earnings Before Interest and Tax (450) (74)
Interest Expense - -
Earnings Before Tax (450) (75)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (450) (75)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (450) (75)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (450) (75)

SKTO SK3 Group, Inc. Research DD Guide

SKTO SK3 Group, Inc. Stock Message Board http://investorshangout.com/search?q=SKTO&...mp;yt0=Go!
SKTO SK3 Group, Inc. Stock Quote http://www.otcmarkets.com/stock/SKTO/quote
SKTO SK3 Group, Inc. Stock Chart http://www.otcmarkets.com/stock/SKTO/chart
SKTO SK3 Group, Inc. Company Info http://www.otcmarkets.com/stock/SKTO/company-info
SKTO SK3 Group, Inc. Recent News http://www.otcmarkets.com/stock/SKTO/news
SKTO SK3 Group, Inc. Financials http://www.otcmarkets.com/stock/SKTO/financials
SKTO SK3 Group, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/SKTO/filings
SKTO SK3 Group, Inc. Short Sales http://www.otcmarkets.com/stock/SKTO/short-sales
SKTO SK3 Group, Inc. Insider Disclosure http://www.otcmarkets.com/stock/SKTO/insider-transactions
SKTO SK3 Group, Inc. Research Reports http://www.otcmarkets.com/stock/SKTO/research
SKTO SK3 Group, Inc. Summary http://finance.yahoo.com/q?s=SKTO
SKTO SK3 Group, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=SKTO+Historical+Prices
SKTO SK3 Group, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=SKTO
SKTO SK3 Group, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=SKTO+Basic+Chart
SKTO SK3 Group, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=SKTO+Basic+Tech.+Analysis
SKTO SK3 Group, Inc. Headlines http://finance.yahoo.com/q/h?s=SKTO+Headlines
SKTO SK3 Group, Inc. Press Releases http://finance.yahoo.com/q/p?s=SKTO+Press+Releases
SKTO SK3 Group, Inc. Company Profile http://finance.yahoo.com/q/pr?s=SKTO+Profile
SKTO SK3 Group, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=SKTO+Key+Statistics
SKTO SK3 Group, Inc. Industry http://finance.yahoo.com/q/in?s=SKTO+Industry
SKTO SK3 Group, Inc. Major Holders http://finance.yahoo.com/q/mh?s=SKTO+Major+Holders
SKTO SK3 Group, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=SKTO+Insider+Transactions
SKTO SK3 Group, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=SKTO+Insider+Roster
SKTO SK3 Group, Inc. Income Statement http://finance.yahoo.com/q/is?s=SKTO
SKTO SK3 Group, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=SKTO
SKTO SK3 Group, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=SKTO+Cash+Flow&annual
SKTO SK3 Group, Inc. Nasdaq http://www.nasdaq.com/symbol/SKTO
SKTO SK3 Group, Inc. Market Watch http://www.marketwatch.com/investing/stock/SKTO
SKTO SK3 Group, Inc. Bloomberg http://www.bloomberg.com/quote/SKTO:US
SKTO SK3 Group, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=SKTO
SKTO SK3 Group, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=SKTO
SKTO SK3 Group, Inc. Barchart http://www.barchart.com/quotes/stocks/SKTO
SKTO SK3 Group, Inc. OTC Short Report http://otcshortreport.com/index.php?index=SKTO
SKTO SK3 Group, Inc. Investopedia http://www.investopedia.com/markets/stocks/SKTO/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 37

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Growth of Middle-Class Investors through Mutual Fund Ownership

Updated Category News Views 149

Mutual Funds and the Rise of the Middle-Class Investor Over recent years, mutual fund ownership has surged among middle-class families. According to insights from the Investment Company Institute (ICI), this trend signifies a vital transition as middle-income households increasingly seek investment opportunities. The growing presence of mutual funds in the American...

Continue Reading
Rques Exchange Reinforces Its Brand with Compliance Strategy

Updated Category News Views 180

Rques Exchange Reinforces Brand with Regulatory Frameworks Rques Exchange is taking significant steps to enhance its brand by emphasizing its commitment to regulatory alignment, operational transparency, and governance integrity in various markets. With global authorities increasingly scrutinizing digital asset platforms, Rques aims to position itself as a technology...

Continue Reading
Business Growth and Confidence: Provident Bank's Insights

Updated Category News Views 120

Increasing Business Confidence for the Future Recently, Provident Bank, a prominent financial institution based in New Jersey, conducted an enlightening Economic Outlook survey. This survey reflects the sentiments of 1,000 business leaders regarding the 2025 economic prospects. The results showcase a robust sense of optimism and confidence among businesses as they look...

Continue Reading
Performance Food Group Co: A Five-Year Stock Journey

Updated Category News Views 219

Unlocking the Value of Investment in Performance Food Group Co Performance Food Group Co (NYSE: PFGC) has delivered impressive returns over the last five years, standing out in the competitive market landscape. With an annualized return that has surpassed the market by 9.42%, investors have seen an average growth rate of around 24.5%. This stock is not just another entry...

Continue Reading
Understanding Rathbones Group Plc's Disclosure Requirements

Updated Category News Views 227

Key Information on Disclosure Requirements Understanding how companies disclose their shareholding is crucial for investors and stakeholders alike. Rathbones Group Plc plays an essential role in managing these disclosures, particularly regarding relevant securities that represent substantial interests in listed companies. Full Name of the Discloser The full name of the...

Continue Reading